W.A.B.M. Bolle

QUALITY OF LIFE EFFECTS OF INTERMITTENT AND CONTINUOUS HORMONAL THERAPY BY CYPROTERONE ACETATE (CPA) FOR METASTATIC PROSTATE CANCER

F. Schröder, P. Verhagen, C. Bangma, 2008 .

Longitudinal evaluation of cytogenetic aberrations in prostatic cancer: tumours that recur in time display an intermediate genetic status between non‐persistent and metastatic tumours

T. H. van der Kwast, H. van Dekken, F. Bosman, 1998, The Journal of pathology.